Clinical efficacy of adjuvant chemotherapy in stage IB (< 4 cm) non-small cell lung cancer patients with high-risk factors

BACKGROUND/AIMS: Adjuvant chemotherapy is the standard of care for resected stage II–IIIA non-small cell lung cancer (NCSLC). The efficacy of adjuvant chemotherapy in stage IB (< 4 cm) NSCLC with high-risk factors is controversial. METHODS: This retrospective multicenter study included 285 stage...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Juwhan, Oh, Jee Youn, Lee, Young Seok, Min, Kyung Hoon, Shim, Jae Jeong, Choi, Sue In, Park, Dong Won, Park, Chan Kwon, Kang, Eun Joo, Yong, Hwan Seok, Shin, Bong Kyung, Kim, Hyun Koo, Lee, Sung Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747921/
https://www.ncbi.nlm.nih.gov/pubmed/32872735
http://dx.doi.org/10.3904/kjim.2020.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8747921/
https://www.ncbi.nlm.nih.gov/pubmed/32872735
http://dx.doi.org/10.3904/kjim.2020.011

Ejemplares similares